Related Experiment Video
Updated: Feb 1, 2026

An In Vitro Assay to Detect tRNA-Isopentenyl Transferase Activity
Published on: October 8, 2018
Wobble uridine tRNA modification: a new vulnerability of refractory melanoma
Francesca Rapino1, Pierre Close1,2
1Laboratory of Cancer Signaling, GIGA-Molecular Biology of Diseases, Interdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège, Liège, Belgium.
Abstract:
The enzymes catalysing the modification of the wobble uridine (U34) of tRNAs (U34-enzymes) play an important role in tumor development. We have recently demonstrated that the U34-enzymes are crucial in the survival of glycolytic melanoma cultures through a codon-specific regulation of HIF1α mRNA translation. Moreover, depletion of U34-enzymes resensitizes resistant melanoma to targeted therapy. These results indicate that targeting U34-enzymes represents a new therapeutic opportunity for melanoma patients.
Insights
Enzymes modifying wobble uridine (U34) in tRNAs are vital for melanoma survival and targeted therapy resistance. Inhibiting these U34-enzymes offers a new therapeutic strategy for melanoma patients.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Enzymes modifying wobble uridine (U34) of tRNAs (U34-enzymes) are implicated in tumor development.
- These enzymes regulate key cellular processes, including translation and metabolic pathways.
Purpose of the Study:
- To investigate the role of U34-enzymes in melanoma survival and response to targeted therapy.
- To explore the potential of targeting U34-enzymes as a therapeutic strategy for melanoma.
Main Methods:
- Utilized glycolytic melanoma cell cultures.
- Investigated codon-specific regulation of HIF1α mRNA translation.
- Assessed the effect of U34-enzyme depletion on melanoma cell survival and drug resistance.
Main Results:
- U34-enzymes are crucial for the survival of glycolytic melanoma cultures.
- These enzymes regulate HIF1α mRNA translation in a codon-specific manner.
- Depletion of U34-enzymes resensitizes resistant melanoma to targeted therapy.
Conclusions:
- Targeting U34-enzymes represents a novel therapeutic opportunity for melanoma.
- U34-enzyme modulation can overcome resistance to existing melanoma treatments.
Related Concept Videos
tRNA Activation
tRNA Activation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
Spreading of Chromatin Modifications
Writers
The writer...
Behavior Modification
A real-world application of operant conditioning principles is applied...

